Mark Maurer

5.2k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Mark Maurer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark Maurer has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Mark Maurer's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and T-cell and B-cell Immunology (4 papers). Mark Maurer is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and T-cell and B-cell Immunology (4 papers). Mark Maurer collaborates with scholars based in United States, Germany and Slovakia. Mark Maurer's co-authors include Alan J. Korman, Julien Fourcade, Zhaojun Sun, Hong Wang, John M. Kirkwood, Cindy Sander, Hassane M. Zarour, Ornella Pagliano, Joë-Marc Chauvin and Tseng-hui Timothy Chen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

In The Last Decade

Mark Maurer

17 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

2015 608 citations Joë-Marc Chauvin, Ornella Pagliano et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Maurer United States	13	783	669	274	175	160	17	1.5k
Akitomo Miyamoto Japan	14	773 1.0×	456 0.7×	87 0.3×	557 3.2×	87 0.5×	20	1.5k
Gary Elliott United States	16	612 0.8×	440 0.7×	46 0.2×	930 5.3×	101 0.6×	22	1.8k
Gábor Gyülvészi Switzerland	8	1.1k 1.4×	233 0.3×	133 0.5×	186 1.1×	43 0.3×	9	1.4k
Bernd Algermissen Germany	14	457 0.6×	240 0.4×	140 0.5×	262 1.5×	163 1.0×	26	956
Maria H. Ulvmar Sweden	16	528 0.7×	959 1.4×	82 0.3×	506 2.9×	50 0.3×	24	1.5k
Zahava Vadasz Israel	21	483 0.6×	118 0.2×	79 0.3×	384 2.2×	45 0.3×	74	1.3k
Remedios Nazareno United States	13	492 0.6×	104 0.2×	113 0.4×	428 2.4×	65 0.4×	14	1.3k
Amalia Lamana Spain	18	518 0.7×	193 0.3×	33 0.1×	368 2.1×	106 0.7×	44	1.1k
MA Shipp United States	13	187 0.2×	544 0.8×	47 0.2×	388 2.2×	101 0.6×	14	1.2k
Cariel Taylor-Edwards United States	9	996 1.3×	353 0.5×	29 0.1×	277 1.6×	36 0.2×	10	1.6k

Countries citing papers authored by Mark Maurer

Since Specialization

Citations

This map shows the geographic impact of Mark Maurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Maurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Maurer more than expected).

Fields of papers citing papers by Mark Maurer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Maurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Maurer. The network helps show where Mark Maurer may publish in the future.

Co-authorship network of co-authors of Mark Maurer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Maurer. A scholar is included among the top collaborators of Mark Maurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Maurer. Mark Maurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Maurer, Mark, Katherine E. Lewis, Joseph L. Kuijper, et al.. (2022). The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity. Nature Communications. 13(1). 1790–1790. 20 indexed citations

Ascierto, Paolo A., Petri Bono, Shailender Bhatia, et al.. (2017). Efficacy of BMS-986016, a monoclonal antibody that targets lymphocyte activation gene-3 (LAG-3), in combination with nivolumab in pts with melanoma who progressed during prior anti–PD-1/PD-L1 therapy (mel prior IO) in all-comer and biomarker-enriched populations. Annals of Oncology. 28. v611–v612. 119 indexed citations

Bezman, Natalie, Ty Brender, Mark Maurer, et al.. (2017). PD-1 blockade enhances elotuzumab efficacy in mouse tumor models. Blood Advances. 1(12). 753–765. 42 indexed citations

Lewis, Katherine E., Matthew S. Holdren, Mark Maurer, et al.. (2016). Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL‐31 neutralizing antibody. Journal of the European Academy of Dermatology and Venereology. 31(1). 142–150. 34 indexed citations

Chauvin, Joë-Marc, Ornella Pagliano, Julien Fourcade, et al.. (2015). TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients. Journal of Clinical Investigation. 125(5). 2046–2058. 608 indexed citations breakdown →

Maurer, Mark, Ursula Garrigues, Stephen R. Jaspers, et al.. (2012). Generation and characterization of human anti-human IL-21 neutralizing monoclonal antibodies. mAbs. 4(1). 69–83. 12 indexed citations

Maurer, Mark, et al.. (2011). Significance of Sesamoid Ossification in Peroneus Longus Tendon Ruptures. The Journal of Foot & Ankle Surgery. 51(3). 352–355. 10 indexed citations

Dillon, Stacey R., Brandon Harder, Kenneth B. Lewis, et al.. (2010). B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin. Arthritis Research & Therapy. 12(2). R48–R48. 81 indexed citations

Ellsworth, Jeff L., Nels Hamacher, Brandon Harder, et al.. (2010). Generation of a high-affinity Fc receptor by Ig-domain swapping between human CD64A and CD16A. Protein Engineering Design and Selection. 23(4). 299–309. 5 indexed citations

10.

Bort, Susan, et al.. (2009). Anti-IL-21 monoclonal antibody reduces disease severity and inflammatory cytokines in a murine model of psoriasis and colitis (97.16). The Journal of Immunology. 182(Supplement_1). 97.16–97.16. 1 indexed citations

11.

Ellsworth, Jeff L., Mark Maurer, Brandon Harder, et al.. (2008). Targeting Immune Complex-Mediated Hypersensitivity with Recombinant Soluble Human FcγRIA (CD64A). The Journal of Immunology. 180(1). 580–589. 25 indexed citations

12.

Bilsborough, Janine, Donald Y.M. Leung, Mark Maurer, et al.. (2006). IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology. 117(2). 418–425. 265 indexed citations

13.

Holloway, James L., et al.. (2000). Molecular cloning, chromosome mapping and characterization of a testis-specific cystatin-like cDNA, cystatin T. Gene. 245(1). 103–108. 25 indexed citations

14.

Whitmore, Theodore E., Jim Holloway, Catherine Lofton–Day, et al.. (2000). Human secretin (SCT): gene structure, chromosome location, and distribution of mRNA. Cytogenetic and Genome Research. 90(1-2). 47–52. 29 indexed citations

15.

Conklin, Darrell, Mark W. Rixon, Rolf Kuestner, et al.. (2000). Cloning and gene expression of a novel human ribonucleoprotein. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1492(2-3). 465–469. 22 indexed citations

16.

Conklin, Darrell, Debra G. Gilbertson, Mark Maurer, et al.. (1999). Identification of a Mammalian Angiopoietin-Related Protein Expressed Specifically in Liver. Genomics. 62(3). 477–482. 139 indexed citations

17.

Maurer, Mark, et al.. (1994). Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.. PubMed. 70(5). 667–75. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact